Find uplifting stories about heroes, innovations, and solutions
6 results for "patient survival"
A new pill targeting the KRAS mutation doubles survival time in pancreatic cancer patients, marking the biggest treatment breakthrough ever for one of the world's deadliest cancers. After 25 years of research and $17 million in funding, scientists are finally seeing progress on multiple fronts at once.
After 40 years without progress, three experimental drugs are giving hope to pancreatic cancer patients, with one treatment doubling survival time from six months to over a year. The breakthroughs could transform one of the deadliest cancer diagnoses into a more manageable disease.
A daily pill for advanced pancreatic cancer nearly doubled survival time in a major trial, offering new hope for one of the deadliest cancers. Patients lived a median of 13.2 months compared to 6.7 months with standard chemotherapy.
A breakthrough drug called daraxonrasib has shown it can extend survival in pancreatic cancer patients, one of medicine's toughest challenges. The announcement from Revolution Medicines marks what experts are calling a new era in treating this devastating disease.
A new once-daily pill for pancreatic cancer nearly doubled patient survival in a groundbreaking late-stage study. The experimental drug offers fresh hope for one of the deadliest forms of cancer.
A new treatment for ALS significantly extended patient survival and delayed the need for breathing support in a Phase 2 trial, offering rare evidence of disease modification. AP-101 works by clearing toxic protein clumps that damage nerve cells in people with the fatal disease.